Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2026-01-01 @ 11:50 AM
Study NCT ID:
NCT00380835
Status:
WITHDRAWN
Last Update Posted:
2008-09-23
First Post:
2006-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
Sponsor:
Celgene Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-12
Completion Date Type:
None
First Submit Date:
2006-09-26
First Submit QC Date:
None
Study First Post Date:
2006-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-09-22
Last Update Post Date:
2008-09-23
Last Update Post Date Type:
ESTIMATED